Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Miguel Pardos
CEO | Chief Executive Officer | - | 01/06/22 |
Santiago Calavia
PRN | Corporate Officer/Principal | - | - |
Julie Moreau
PRN | Corporate Officer/Principal | - | - |
Kamal Abbasi
PRN | Corporate Officer/Principal | - | - |
Jayne Burrell
LAW | General Counsel | 50 | 02/01/15 |
Nairn McMaster
PRN | Corporate Officer/Principal | - | 01/07/11 |
Emilie Croissant
SAM | Sales & Marketing | - | - |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Cheng Wei Liu
CHM | Chairman | 50 | - |
Miguel Pardos
CEO | Chief Executive Officer | - | 01/06/22 |
Gen Li
BRD | Director/Board Member | - | 27/04/23 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 580 157 084 | 315 849 061 ( 54,44 %) | 0 | 54,44 % |
Coordinate società
Sinclair Pharma Ltd.
Whitfield Court 30-32 Whitfield Street
W1T 2RQ, London
+44 20 7467 6920
http://www.sinclairpharma.com![Indirizzo Sinclair Pharma PLC](https://cdn.zonebourse.com/static/address/4004466.png)
Settore
Variaz. 1 gen. | Capi. | |
---|---|---|
+22,20% | 44,09 Mrd | |
+29,53% | 23,18 Mrd | |
+21,32% | 15,66 Mrd | |
+19,06% | 14,35 Mrd | |
+59,28% | 13,2 Mrd | |
-0,05% | 6,79 Mrd | |
-11,72% | 6,45 Mrd | |
-8,87% | 5,73 Mrd | |
+14,11% | 5,63 Mrd |